RegASK sponsors RAPS Convergence 2025
RegASK is proud to participate in RAPS Convergence 2025, the largest annual gathering for regulatory affairs professionals, bringing togethe…
Read more
$7 Billion Parkinson’s Disease Market by 2033: Implic…
On August 5, 2025, Clinical Trials Arena released a market forecast detailing significant growth in Parkinson’s disease (PD) therapeutics …
Read more
Major U.S. Reform Bill Triggers Regulatory Consequences…
July 4, 2025 – In a move set to reshape key sectors, U.S. President Donald Trump has signed into law H.R.1 – the “One Big Beautiful Bi…
Read more
FDA Launches “Elsa”: Agency-Wide Generative…
On June 2, 2025, the U.S. Food and Drug Administration (FDA) officially launched Elsa, a generative artificial intelligence (AI) tool develo…
Read more
Powering Global Hybrid Clinical Trials: Simplified, Com…
The Challenge A leading global pharmaceutical company was preparing to scale hybrid clinical trials for its Food for Special Medical Purpose…
Read more
Breaking Into the US: Compliant Claims for an Innovativ…
The Challenge Bringing an infant formula to the U.S. market isn’t just about innovation. It’s about navigating one of the most rigorous …
Read more
Esko and RegASK Partner to Transform Packaging Complian…
ST. LOUIS & NEW YORK–(BUSINESS WIRE)–RegASK, a leading provider of AI-driven regulatory intelligence for Consumer Goods and …
Read more
MAHA Commission Releases Report on U.S. Childhood Chron…
Presidential Commission Releases Landmark Report on U.S. Childhood Chronic Disease Crisis May 22, 2025 – The Presidential Commission to Ma…
Read more
EPA Proposes Renewal of Hazardous Remediation Waste Ove…
May 23, 2025 – The U.S. Environmental Protection Agency (EPA) has proposed a renewal of its Information Collection Request (ICR) related t…
Read more
California Suspends Proposed Bill Restricting Sale of A…
On May 15, 2025, the California Legislature paused Assembly Bill 728 (AB 728), a proposed law that would restrict the sale of certain over-t…
Read more